When researchers analyzed weight loss results from patients who took GLP-1 drugs and those who'd undergone bariatric surgery, one method led to much more weight loss.

Many focus on what weight-loss drugs take away: pounds. But they also offer patients something new: a sense of agency.

Eli Lilly will ship the two highest doses of its popular weight-loss drug Zepbound to cash-paying customers on its website ...

Pennsylvania Governor Josh Shapiro's office has said it is looking to change eligibility for weight loss drugs as part of its ...

Eli Lilly's drug, called eloralintide, helped some patients lose more than 11% of their body weight in three months.

An investigational drug developed by Eolo Pharma is showing promise in animal experiments and an early human trial. It could eventually be an alternative or add-on to popular GLP-1 medications.

suburbs to South Jersey and Delaware, what would you like WHYY News to cover? Let us know! Ever since blockbuster weight-loss drugs like Wegovy and Zepbound went mainstream, calls to local poison ...

Dr. Shervin Naderi and his team integrate facial rejuvenation with weight loss care to manage the structural facial changes ...

With the addition of 12.5 mg and 15 mg vials, all approved doses of Zepbound will be available in single-dose vials for $499 /month or less, regardless of insurance ...

Temple University physician Rohit Soans worries that patients using weight-loss medications may be considering risky options to keep taking these popular drugs. As new restrictions on popular GLP-1 ...

What happens when you stop taking weight loss drugs like Mounjaro and Ozempic? - Studies find that many people return to ...

In 2025, it feels like prescription weight-loss drugs have gone from mainstream to mania—we all know someone (or many someones) using them, and ads for different versions have taken over our ...